CBU
BSX icon

CIBC Bancorp USA’s Boston Scientific BSX Stock Holding History

CIBC Bancorp USA’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$30.2M Sell
706,276
-1,235,149
-64% -$67.1M 0.04% 328
2026
Q1 		$122M Buy
+1,941,425
New +$155M 0.16% 136
2025
Q3 		$59M Buy
+604,347
New +$62.6M 0.32% 51

Other funds holding BSX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

CIBC Bancorp USA's BSX Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Boston Scientific (BSX) stake by 64% in Q2 2026, selling an estimated $67.1M and leaving 706,276 shares worth $30.2M. The position accounts for 0.04% of the portfolio, ranked #328.

CIBC Bancorp USA first reported a position in BSX in Q3 2025 and has held it in 3 quarters since. The position peaked at $122M in Q1 2026. 1,381 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • CIBC Bancorp USA held 706,276 shares of Boston Scientific worth $30.2M as of Q2 2026.
  • CIBC Bancorp USA sold 1,235,149 Boston Scientific shares in Q2 2026, an estimated $67.1M.
  • Boston Scientific made up 0.04% of CIBC Bancorp USA's portfolio in Q2 2026, its #328 holding.
  • CIBC Bancorp USA first reported a position in Boston Scientific in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Boston Scientific position peaked at $122M in Q1 2026.
  • 1,381 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.